A J Sleight1, F G Boess, M Bös
1Pharma Division, Preclinical Research, F. Hoffmann-La Roche, Basel, Switzerland. andrew__john.sleight@roche.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers explored the novel 5-HT6 receptor, a newly discovered target for the neurotransmitter serotonin (5-hydroxytryptamine). This review details its cloning, distribution, and functional evidence, opening avenues for new therapeutic applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: